Top Qs
Timeline
Chat
Perspective
Robatumumab
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
Robatumumab (proposed INN; also known as SCH 717454 and MK-7454) is a monoclonal antibody and an antineoplastic by Merck and Schering-Plough. It binds to CD221, the insulin-like growth factor 1 receptor.[1]
Phase 2 clinical trials in patients with colorectal cancer, osteosarcoma and Ewing's sarcoma are complete.[2][3] Merck has since discontinued development.[4]
Remove ads
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads